Browsing Tag
Regenerative Medicine
31 posts
Why Heart3D fusion imaging could become critical for scaling cardiac cell therapy platforms
Find out how BioCardia, Inc.’s Heart3D imaging platform could solve scalability challenges in cardiac cell therapy and reshape regenerative medicine.
April 30, 2026
What rezanecel’s durability data means for epilepsy treatment innovation
Neurona Therapeutics’ rezanecel shows durable seizure reduction. Discover what this means for epilepsy treatment innovation and future market dynamics.
April 24, 2026
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
UCB is acquiring Neurona for up to $1.15 billion to deepen its epilepsy pipeline. Read what the deal means for growth, risk, and biotech competition.
April 18, 2026
Can deeper university alliances help Propanc Biopharma, Inc. stabilize its clinical transition?
Propanc Biopharma expands university research partnerships as it enters human trials. Discover what this signals for strategy, risk, and investors.
March 27, 2026
Is this the biomarker breakthrough Longeveron Inc. needs to reach Phase 3?
Can biomarker-linked response boost laromestrocel’s Phase 3 prospects? Explore regulatory, financial, and industry implications.
February 28, 2026
Longeveron Inc. appoints Stephen H. Willard as CEO ahead of pivotal Phase 2b stem cell data
Find out why Longeveron Inc.’s CEO appointment comes at a critical clinical and financial moment and what it could mean for investors and regenerative medicine.
February 14, 2026
BioStem Technologies (OTC: BSEM) acquires BioTissue wound care unit to expand hospital market presence
BioStem acquires BioTissue’s wound care business for $15M, gaining GPO access, sales force, and acute care exposure. Find out what this means for growth.
January 23, 2026
Emmecell names ex-AbbVie executive Ramin Valian as CEO to lead cell therapy platform
Emmecell names Ramin Valian as CEO to guide its magnetic cell delivery platform toward pivotal trials. Find out what this leadership shift means for the industry.
January 18, 2026
Could this tiny biotech help fix transplant logistics? LifeNet Health thinks so
LifeNet Health acquires Tissue Testing Technologies to scale cryopreservation in transplants. Find out how this deal reshapes regenerative medicine.
December 16, 2025
FDA nod sends Organogenesis shares higher as ReNu eyes BLA filing for knee osteoarthritis pain
Find out how Organogenesis’ FDA alignment clears the path for a ReNu BLA filing in knee osteoarthritis pain and why investors are paying attention now.
December 16, 2025